| Cell Responses to IFN-gamma (NCT01317017) | Rockefeller University | 2010-07-01 |
| Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020) (NCT01140061) | Merck Sharp & Dohme LLC | 2010-05-01 |
| Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects (NCT01010542) | Pfizer | 2009-12-01 |
| Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis (NCT00832364) | Stiefel, a GSK Company | 2009-10-01 |
| Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis (NCT00988637) | Galderma R&D | 2009-10-01 |
| Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients (NCT00884169) | Maruho Co., Ltd. | 2009-07-01 |
| Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis (NCT00924950) | University of California, San Francisco | 2009-06-01 |
| BTT1023 in Psoriasis (NCT00871598) | Biotie Therapies Corp. | 2009-03-01 |
| The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab (NCT00833729) | Dermatrials Research | 2009-02-01 |
| Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis (NCT01111123) | Icahn School of Medicine at Mount Sinai | 2009-01-01 |
| A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis (NCT00796211) | Zalicus | 2008-11-01 |
| A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis (NCT00746434) | AstraZeneca | 2008-11-01 |
| ACT-128800 in Psoriasis (NCT00852670) | Actelion | 2008-10-01 |
| Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis (NCT00663052) | Pfizer | 2008-06-01 |
| Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00691964) | AbbVie (prior sponsor, Abbott) | 2008-05-01 |
| Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva) (NCT00608777) | Derm Research, PLLC | 2008-01-01 |
| Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis (NCT00555646) | Provectus Pharmaceuticals | 2007-11-01 |
| A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00570986) | AbbVie (prior sponsor, Abbott) | 2007-11-01 |
| Study of CRx-191 to Assess Activity in Plaque Psoriasis (NCT00557739) | Zalicus | 2007-11-01 |
| Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects (NCT00658606) | Astellas Pharma Inc | 2007-10-01 |
| Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis (NCT00581100) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-09-01 |
| Safety and Efficacy Study of CF101 to Treat Psoriasis (NCT00428974) | Can-Fite BioPharma | 2007-06-01 |
| NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study (NCT00708851) | NeoStrata Company, Inc. | 2007-04-01 |
| Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept (NCT00927069) | Innovaderm Research Inc. | 2007-03-01 |
| A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis (NCT00669916) | Novartis Pharmaceuticals | 2007-02-01 |
| Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate (NCT01228656) | Azidus Brasil | 2006-09-01 |
| A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis (NCT00302445) | Derm Research, PLLC | 2006-03-01 |
| Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program (NCT00371774) | Astellas Pharma Inc | 2005-06-01 |
| Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis (NCT00184366) | Norwegian University of Science and Technology | 2005-05-01 |
| Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis (NCT00227240) | Pfizer | 2005-04-01 |
| A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis (NCT00382512) | Genentech, Inc. | 2003-05-01 |
| A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis (NCT00540618) | MedImmune LLC | 2001-09-01 |
| Treatment of Psoriasis With Parathyroid Hormone (NCT00007306) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2000-01-01 |